PATENT CLAIM ANALYSIS

Application Number: 15769713
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "417000"]

Abstract:
Methods of treating immune reconstitution inflammatory syndrome (IRIS) in immunodeficient patients, including HIV patients, using PDE4 modulators are described.

Claim (Index 56):
The PDE4 modulator for use of any one of  claims 30  to  52 , wherein said IRIS is characterized by or results from cytomegalovirus (CMV), CMV retinitis,  crytoccocal meningitis, croyptococcosis , eosinophilic folliculitis, hepatitis B, hepatitis C, herpes virus, herpes simplex virus (HSV), varicella zoster virus (shingles), human pampillomavirus (HPV), karposi sarcoma (HHV8),  Mycobacterium avium  complex (MAC),  Pneumocystis  jiroveci pneumonia (PCP), progressive multifocal leukoencephalopathy (PML), or  Mycobacterium tuberculosis  (TB).

Metadata:
- Claim Count in Document: 67.0
- Percentile: 91.0
- Lexical Diversity: 1.09091
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10534325', '10531552', '10392195', '10515270', '10794931']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7241355753025371
- 35 USC 102 Novelty (BERT): 0.5067967213306733
- Combined Prediction Score: 0.7024016899053508
- Mean Citation Score: 179.10226400000005
- Max Citation Score: 196.59668
- Similarity Product: 123.45229007776736

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test